Table 2.
Univariate analysis of clinicopathological features for overall survival of patients with intrahepatic cholangiocarcinoma.
| Characteristics (n = 100) | Number | Survival rate (%) | P ∗ |
|---|---|---|---|
| Gender | 0.064 | ||
| Female | 31 | 32.3 | |
| Male | 69 | 34.8 | |
| Age (years) | 0.325 | ||
| <60 | 52 | 38.5 | |
| ≥60 | 48 | 29.2 | |
| SHMT2 expression | 0.030∗ | ||
| Low | 48 | 45.8 | |
| High | 52 | 23.1 | |
| Vascular invasion | 0.470 | ||
| No | 64 | 31.3 | |
| Yes | 36 | 38.9 | |
| Tumor number | 0.012∗ | ||
| Solitary | 91 | 35.2 | |
| Multiple | 9 | 22.2 | |
| Tumor size (cm) | 0.484 | ||
| ≤5 | 40 | 32.5 | |
| >5 | 60 | 35.0 | |
| Pathological grade | 0.800 | ||
| I | 4 | 50 | |
| II | 62 | 33.9 | |
| III | 34 | 32.4 | |
| T stage | <0.001∗ | ||
| T1 | 42 | 40.5 | |
| T2 | 47 | 34.0 | |
| T3–T4 | 11 | 9.0 | |
| N stage | 0.888 | ||
| N0 | 86 | 33.7 | |
| N1 | 14 | 35.7 | |
| Metastasis | 0.073 | ||
| No | 96 | 35.4 | |
| Yes | 4 | 0 | |
| TNM stage | 0.058 | ||
| I | 34 | 38.2 | |
| II | 42 | 35.7 | |
| III–IV | 24 | 25.0 |